| Revista: | The brazilian journal of infectious diseases |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000290980 |
| ISSN: | 1413-8670 |
| Autores: | Sabbatani, Sergio1 Giuliani, Ruggero Manfredi, Roberto2 |
| Instituciones: | 1Universita degli Studi di Bologna "Alma Mater Studiorum", Divisione di Malattie Infettive, Bolonia, Emilia Romaña. Italia 2Universita degli Studi di Bologna "Alma Mater Studiorum", Dipartimento di Medicina Clinica e Sperimentale, Bolonia, Emilia Romaña. Italia |
| Año: | 2006 |
| Periodo: | Ago |
| Volumen: | 10 |
| Número: | 4 |
| Paginación: | 274-278 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Experimental |
| Resumen en inglés | The elevated frequency of chronic hepatitis C virus (HCV) infection found among prison inmates, and the availability of improved pharmacological cure for this potentially life-threatening disorder, make investigations conducted in this somewhat neglected area very relevant, since only a few, open-label experiences have been reported till now. In the metropolitan prison of Bologna (Italy), HCV seroprevalence was found to be over 31% in 2003, so that a pilot feasibility study based on treatment with pegylated interferon plus ribavirin was initiated, after careful counseling carried out by a joint commission of health care personnel of the correctional facility and infectious diseases consultants. Thirty-nine patients were enrolled, and despite expected dropouts due to difficulty in maintaining the same level of counseling pressure over time, and the particularly unfavorable climatic conditions during Summer 2003, a sustained virological response was obtained for 8 out of the 21 patients who remained evaluable after the first three month follow-up, although we need to take into account that a high percentage of subjects (67%) were selected for therapy due to their favorable HCV genotypes (types 2 and 3). Our preliminary experience shows that an intrinsically complicated therapy, such as the administration of pegylated interferon plus ribavirin, can attain a relatively high success rate, even in a very unfavorable and uncomfortable context, such as a prison, where only enforced counseling, active participation of institutional health c |
| Disciplinas: | Medicina, Química |
| Palabras clave: | Terapéutica y rehabilitación, Bioquímica, Inmunología, Hepatitis C, Hepatitis crónica, Interferón pegilado, Ribavirina, Manejo, Reclusos, Prisioneros |
| Keyword: | Medicine, Chemistry, Therapeutics and rehabilitation, Biochemistry, Prisons, Chronic hepatitis, Hepatitis C, Pegylated interferon, Ribavirin, Management, Inmates, Immunology |
| Texto completo: | Texto completo (Ver HTML) |
